BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18628631)

  • 1. Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes.
    Kobessho H; Oishi K; Hamaguchi H; Kanda F
    Eur Neurol; 2008; 60(3):132-6. PubMed ID: 18628631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal anaesthesia with 0.5% isobaric bupivacaine in patients with diabetes mellitus: the influence of CSF composition on sensory and motor block.
    Echevarria M; Hachero A; Martinez A; Ramallo E; García-Bernal D; Ramos M; Fernández A
    Eur J Anaesthesiol; 2008 Dec; 25(12):1014-9. PubMed ID: 18990259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cerebrospinal fluid protein is unnecessary in children with leukemia.
    Barber A; Lovato J; Hill G; McLean TW
    Pediatr Blood Cancer; 2008 Sep; 51(3):428-30. PubMed ID: 18454465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetogenous changes in the CNS and their pneumoencephalographic and csf findings].
    Glasner H; Piepgras U; Pauly A
    Nervenarzt; 1975 Nov; 46(11):636-9. PubMed ID: 1202369
    [No Abstract]   [Full Text] [Related]  

  • 7. A cerebrospinal fluid glucose biosensor for diabetes mellitus.
    Gilbert JW; Weiser HC; Holladay FP
    ASAIO J; 1992; 38(2):82-7. PubMed ID: 1421610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of lumbar CSF protein concentration.
    Seyfert S; Kunzmann V; Schwertfeger N; Koch HC; Faulstich A
    J Neurol; 2002 Aug; 249(8):1021-6. PubMed ID: 12195448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of cerebrospinal fluid associated with canine granulomatous meningoencephalomyelitis: a retrospective study.
    Bailey CS; Higgins RJ
    J Am Vet Med Assoc; 1986 Feb; 188(4):418-21. PubMed ID: 3949620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase.
    Wiersma JJ; Meuwese MC; van Miert JN; Kastelein A; Tijssen JG; Piek JJ; Trip MD
    Med Sci Monit; 2008 Aug; 14(8):CR406-10. PubMed ID: 18667997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related macular disease in diabetes mellitus.
    Giansanti R; Fumelli C; Boemi M; Fumelli P
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():473-6. PubMed ID: 18653080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin interference in the cerebrospinal fluid protein assay measured with a pyrogallol red-molybdate complex.
    Yang JY; Chien TI; Lu JY; Kao JT
    Clin Chim Acta; 2009 Oct; 408(1-2):75-8. PubMed ID: 19646428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.
    Philips JC; Marchand M; Scheen AJ
    Diabetes Metab Res Rev; 2009 Jul; 25(5):442-51. PubMed ID: 19437445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double protein-cerebrospinal fluid test for the identification of blood contaminants in bloody cerebrospinal fluid].
    Guĭtur MI; Guĭtur MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1802-4. PubMed ID: 7340321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barré syndrome.
    Gonzalez-Quevedo A; Carriera RF; O'Farrill ZL; Luis IS; Becquer RM; Luis Gonzalez RS
    Neurol India; 2009; 57(3):288-94. PubMed ID: 19587469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting.
    Paiva MS; Serrano CV; Nicolau JC; Jalbut BO; Fernandes JL; De Lemos JA; Blotta MH; De Oliveira RT; De Oliveira IR; De Oliveira Lda A; Ramires JA
    J Interv Cardiol; 2008 Oct; 21(5):403-9. PubMed ID: 18705636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample.
    Kumar R; Anstey KJ; Cherbuin N; Wen W; Sachdev PS
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):989-98. PubMed ID: 19038898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions.
    Mehta RH; Honeycutt E; Shaw LK; Sketch MH
    Am Heart J; 2008 Oct; 156(4):728-35. PubMed ID: 18926154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus and long-term outcome in heart failure patients after surgical ventricular restoration.
    Castelvecchio S; Ranucci M; Di Donato M; Menicanti L
    Ann Thorac Surg; 2009 Nov; 88(5):1451-6. PubMed ID: 19853091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.